148 results  1 of 8 

1 Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter study
Ja Min Byun, Sung-Soo Park, Sung-Soo Yoon, Ari Ahn, Myungshin Kim, Jung Yeon Lee, Young-Woo Jeon, Seung-Hwan Shin, Seung-Ah Yahng, Youngil Koh, Chang-Ki Min
Blood Res.2023;58(2):83-90.   Published online 2023 April 7     DOI: http://dx.doi.org/10.5045/br.2023.2023005
      
2 Therapeutic Leukapheresis for Plasma Cell Leukemia Presenting with Hyperleukocytosis: The First Case in Korea
Sooyong Park, Jae Hyeon Park, Yousun Chung, Dae-Hyun Ko, Hyungsuk Kim
Lab Med Online.2023;13(1):36-41.   Published online 2023 January 1     DOI: http://dx.doi.org/10.47429/lmo.2023.13.1.36
      
3 Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma
Fatıma Ceren Tuncel, Istemi Serin, Sacide Pehlivan, Yasemin Oyaci, Mustafa Pehlivan
Blood Res.2022;57(4):250-255.   Published online 2022 December 31     DOI: http://dx.doi.org/10.5045/br.2022.2022097
      
4 Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study
Jongheon Jung, Kihyun Kim, Sung-Hoon Jung, Sung-Soo Yoon, Jae Hoon Lee, Jin Seok Kim, Ho-Jin Shin, Soo-Mee Bang, Sang Kyun Sohn, Cheolwon Suh, Dok Hyun Yoon, Sun-Young Kong, Chang-Ki Min, Hyeon-Seok Eom
Cancer Res Treat.2023;55(2):693-703.   Published online 2022 November 16     DOI: http://dx.doi.org/10.4143/crt.2022.952
      
5 Spheno-Orbital Plasmacytoma as an Initial Presentation of Multiple Myeloma
Sangjun Ahn, Seung Heon Cha, Won Ho Cho
Brain Tumor Res Treat.2022;10(4):270-274.   Published online 2022 October 27     DOI: http://dx.doi.org/10.14791/btrt.2022.0026
      
6 Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
Hyun-Young Kim, In Young Yoo, Dae Jin Lim, Hee-Jin Kim, Sun-Hee Kim, Sang Eun Yoon, Seok Jin Kim, Duck Cho, Kihyun Kim
Ann Lab Med.2022;42(5):558-565.   Published online 2022 September 1     DOI: http://dx.doi.org/10.3343/alm.2022.42.5.558
      
7 Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen
Su-In Kim, Sung-Hoon Jung, Ho-Young Yhim, Jae-Cheol Jo, Ga-Young Song, Mihee Kim, Seo-Yeon Ahn, Jae-Sook Ahn, Deok-Hwan Yang, Hyeoung-Joon Kim, Je-Jung Lee
Blood Res.2022;57(1):51-58.   Published online 2022 March 31     DOI: http://dx.doi.org/10.5045/br.2021.2021176
      
8 Clinical impact of spine magnetic resonance imaging as a valuable prognostic tool for patients with multiple myeloma: a retrospective study
Jung Min Lee, Hee Jeong Cho, Joon-Ho Moon, Sang Kyun Sohn, Byunggeon Park, Dong Won Baek
J Yeungnam Med Sci.2022;39(4):300-308.   Published online 2022 March 23     DOI: http://dx.doi.org/10.12701/jyms.2021.01648
      
9 Unstable Pathologic Vertebral Fractures in Multiple Myeloma : Propensity Score Matched Cohort Study between Reconstructive Surgery with Adjuvant Radiotherapy and Radiotherapy Alone
Hyung-Youl Park, Young-Hoon Kim, Joo-Hyun Ahn, Kee-Yong Ha, Sang-Il Kim, Jae-Woong Jung
J Korean Neurosurg Soc.2022;65(2):287-296.   Published online 2022 January 4     DOI: http://dx.doi.org/10.3340/jkns.2021.0199
      
10 Solitary plasmacytoma in the maxillary sinus: 10-year follow-up
Truc Thi Hoang Nguyen, Mi Young Eo, Buyanbileg Sodnom-Ish, Yun Ju Cho, Soung Min Kim
J Korean Assoc Oral Maxillofac Surg.2021;47(6):471-475.   Published online 2021 December 31     DOI: http://dx.doi.org/10.5125/jkaoms.2021.47.6.471
      
11 Association between Kidney Function, Proteinuria and the Risk of Multiple Myeloma: A Population-Based Retrospective Cohort Study in South Korea
Taewoong Choi, Wooin Ahn, Dong Wook Shin, Kyungdo Han, Dahye Kim, Sohyun Chun
Cancer Res Treat.2022;54(3):926-936.   Published online 2021 September 27     DOI: http://dx.doi.org/10.4143/crt.2021.951
      
12 Oral Phase Dysphagia, the First Manifestation of Systemic Amyloidosis Associated with Multiple Myeloma
Ki Jong Hyun, Sung Hoon Kim, Lucia Kim, Ji Won Kim
Korean J Otorhinolaryngol-Head Neck Surg.2021;64(8):576-579.   Published online 2021 February 10     DOI: http://dx.doi.org/10.3342/kjorl-hns.2020.00402
      
13 반응성 형질세포와 악성 형질세포 감별을 위한 형질세포 선별튜브의 유용성 평가
Hae In Bang, Tae Youn Choi
Lab Med Online.2020;10(4):314-320.   Published online 2020 October 1     DOI: http://dx.doi.org/10.47429/lmo.2020.10.4.314
      
14 고칼슘혈증이 동반된 급성 췌장염에서 진단된 다발성 골수종 환자
Ik Hyun Jo, Chang-Nyol Paik
Korean J Gastroenterol.2020;75(4):220-224.   Published online 2020 April 25     DOI: http://dx.doi.org/10.4166/kjg.2020.75.4.220
      
15 Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow Biopsies
Yousun Chung, Seungwon Shin, Hyoeun Shim, Ji Yeon Sohn, Dong-eun Lee, Hyewon Lee, Hyeon-Seok Eom, Kwang Gi Kim, Sun-Young Kong
Ann Lab Med.2020;40(4):312-316.   Published online 2020 February 17     DOI: http://dx.doi.org/10.3343/alm.2020.40.4.312
      
16 Necrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma
Joon Goon Kim, Hye Ri Kim, Moon Hyung You, Dong Hoon Shin, Jong Soo Choi, Young Kyung Bae
Ann Dermatol.2020;32(1):53-56.   Published online 2019 December 27     DOI: http://dx.doi.org/10.5021/ad.2020.32.1.53
      
17 A Case of Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia with IgM-κ and IgA-λ Biclonal Gammopathy
Woo Yong Shin, Hae In Bang, Jieun Kim, Rojin Park, Jeong Won Shin, Tae Youn Choi
Lab Med Online.2019;9(4):263-268.   Published online 2019 October 1     DOI: http://dx.doi.org/10.3343/lmo.2019.9.4.263
      
18 Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism
David Azoulay, Sami Giryes, Roni Nasser, Rivka Sharon, Netanel A. Horowitz
J Clin Neurol.2019;15(4):511-516.   Published online 2019 August 23     DOI: http://dx.doi.org/10.3988/jcn.2019.15.4.511
      
19 Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30–Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Hye Jin Kang, Hye Won Lee, Hyeon-Seok Eom, Jung Yong Hong, Junhun Cho, Young Hyeh Ko, Jooryung Huh, Woo-Ick Yang, Weon Seo Park, Seung-Sook Lee, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.2020;52(2):374-387.   Published online 2019 August 13     DOI: http://dx.doi.org/10.4143/crt.2019.198
      
20 Frontline therapy for newly diagnosed patients with multiple myeloma
Sung-Hoon Jung, Jae-Cheol Jo, Ga-Young Song, Seo-Yeon Ahn, Deok-Hwan Yang, Jae-Sook Ahn, Hyeoung-Joon Kim, Je-Jung Lee
Blood Res.2020;55(Supplement):S37-S42.   Published online 2019 July 30     DOI: http://dx.doi.org/10.5045/br.2020.S007
      

 1 of 8